Tibet AIM Pharm. Inc. (SHE:002826)
China · Delayed Price · Currency is CNY 15.86
+0.05 (0.32%)
Oct 23, 2026, 3:04 PM CST
Tibet AIM Pharm. Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 684.45 | 636.27 | 651.88 | 667.04 | 856.73 | 725.46 |
Revenue Growth | 11.96% | -2.40% | -2.27% | -22.14% | 18.09% | 20.38% |
Gross Profit Gross Profit Growth | 565.51 | 522.45 | 446.34 | 341.45 | 376.03 | 260.5 |
Operating Income Operating Income Growth | 68 | 64.62 | 27.26 | 24.91 | 46.32 | 41.58 |
Net Income Net Income Growth | 121.7 | 92.58 | 45.93 | 15.39 | 44.14 | 42.48 |
Earnings Per Share EPS Growth | 0.66 | 0.50 | 0.25 | 0.08 | 0.23 | 0.22 |
EPS Growth | 176.60% | 100.00% | 212.50% | -65.22% | 4.54% | 0% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Drug Sales Drug Sales Growth | 684.68 | 635.62 | 568.64 | - | - | - |
Drug Promotion Services Drug Promotion Services Growth | - | -1.1 | 78.6 | - | - | - |
Others Others Growth | -0.03 | 1.75 | 4.65 | 141.53 | 194.63 | 97.1 |
Total Total Growth | 684.45 | 636.27 | 651.88 | 667.04 | 856.73 | 725.46 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 699.34 | 537.66 | 427.4 | 385.86 | 321.28 | 182.73 |
Total Debt Total Debt Growth | 28.8 | 11.26 | 22.82 | 11.01 | 50.05 | - |
Net Cash (Debt) Net Cash Growth | 670.54 | 526.41 | 404.58 | 374.85 | 271.23 | 182.73 |
Net Cash Growth | 42.35% | 30.11% | 7.93% | 38.20% | 48.44% | 10.53% |
Net Cash Per Share Net Cash Per Share Growth | 3.65 | 2.84 | 2.20 | 1.95 | 1.41 | 0.95 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 235.22 | 123.72 | 111.57 | 166.88 | 68.45 | 109.52 |
Capital Expenditures CapEx Growth | -7.47 | -8.5 | -12.24 | -3.18 | -3.2 | -25.2 |
Free Cash Flow Free Cash Flow Growth | 227.75 | 115.22 | 99.33 | 163.7 | 65.26 | 84.33 |
Free Cash Flow Growth | 87.75% | 16.00% | -39.32% | 150.86% | -22.62% | 33.20% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 82.62% | 82.11% | 68.47% | 51.19% | 43.89% | 35.91% |
Operating Margin | 9.93% | 10.15% | 4.18% | 3.73% | 5.41% | 5.73% |
Pretax Margin | 21.55% | 17.87% | 9.26% | 3.54% | 6.62% | 6.89% |
Profit Margin | 17.78% | 14.55% | 7.05% | 2.31% | 5.15% | 5.85% |
FCF Margin | 33.27% | 18.11% | 15.24% | 24.54% | 7.62% | 11.62% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.150 | 0.100 | 0.030 | 0.100 | 0.100 |
Dividend Per Share Growth | 50.00% | 50.00% | 233.33% | -70.00% | 0% | 25.00% |
Dividend Yield | 0.95% | 0.83% | 0.97% | 0.25% | 0.98% | 0.91% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 23.96 | 37.18 | 41.39 | 147.10 | 44.03 | 49.29 |
P/FCF Ratio | 13.24 | 29.87 | 19.14 | 13.83 | 29.78 | 24.83 |
PS Ratio | 4.40 | 5.41 | 2.92 | 3.39 | 2.27 | 2.89 |